The Seed Enterprise Investment Scheme (‘SEIS’) is designed to help small, very early-stage companies to raise equity finance by offering a range of tax reliefs to individual investors who purchase new shares in those companies.
The scheme is complementary to the Enterprise Investment Scheme (‘EIS’) and offers tax relief at a higher rate than that offered by the existing EIS. This Guidance Note provides a high level overview of the SEIS drawing out the most prevalent points of interest and concern for companies in the life sciences sector . . .
This content is restricted to subscribers. To view this content please register an account.
If you are already a subscriber, please login below.